挑战和近期的进步在红色素稳定性
Bahgat Fayed1, Shanshan Luo2, Alaa Eldeen B Yassin3,4
1Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza, Egypt.
Pharmaceutical development and technology
|September 28, 2024
概括
红素 (EPO) 的稳定性对于其在治疗贫血方面的治疗效果至关重要. 研究探讨了增强EPO稳定性的策略,改善药物开发和患者的治疗结果.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 红色素 (EPO) 调节红细胞的产生,复合人体EPO (rh-EPO) 改善了自1989年以来的贫血治疗.
- 埃博主要由脏和肝脏合成.
- rh-EPO广泛用于慢性病,癌症和其他疾病中的贫血.
研究的目的:
- 审查EPO稳定性在维持生物活性和治疗疗效方面的关键作用.
- 检查EPO不稳定性对药物开发和临床结果的影响.
- 综合调查目前稳定EPO的战略.
主要方法:
- 对EPO稳定性,不稳定性因素和稳定技术的文献综述.
- 分析环境条件 (温度,光线) 对EPO的影响.
- 评估配方策略,包括稳定剂,冷化和新型输送系统.
主要成果:
- 由于EPO的不稳定性,以降解和活性丧失为特征,这对治疗疗效构成了挑战.
- 温度波动,曝光和物质相互作用有助于EPO的不稳定性.
- 目前正在开发各种策略,包括辅助剂,冷化和先进配方,以提高EPO的稳定性.
结论:
- 确保EPO稳定性对于成功治疗贫血和有效开发药物至关重要.
- 创新的稳定战略对于克服EPO固有的不稳定性所带来的局限性至关重要.
- 对EPO稳定性的持续研究将改善贫血患者的治疗结果.
相关概念视频
Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
RNA Stability
33.3K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
mRNA Stability and Gene Expression
5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.5K
Lifecycle of Erythrocytes
1.9K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
1.9K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K


